Replies to post #349379 on Anavex Life Sciences Corp (AVXL)

[nor377]

I kind of think that the FDA / Biogen interactions could lead to more two way communications driven by the FDA especially when dealing with an orphan drug for an as yet untreated condition such as Rett. If better measures are more acceptable I would hope that the fda would council a company to make approvals more likely.